Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,996,650
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
61,082,876
-
Shares change
-
+997,332
-
Total reported value, excl. options
-
$816,481,210
-
Value change
-
-$9,337,179
-
Put/Call ratio
-
39%
-
Number of buys
-
69
-
Number of sells
-
43
-
Price
-
$13.37
Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q1 2023
As of 31 Mar 2023 Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) had 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,082,876 shares of stock of the company.
Largest 10 holders included FMR LLC, Atlas Venture Life Science Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC, BRAIDWELL LP, VANGUARD GROUP INC, Canaan Partners XI LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., and STATE STREET CORP.
This table shows 146 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.